# Kristen Pogue

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kristen-pogue/

## Facts

| Field | Value |
| --- | --- |
| Citations | 402 |
| Field | Heart Failure Treatment and Management |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | University School |
| OpenAlex ID | https://openalex.org/A5068813504 |
| ORCID iD | 0000-0002-2645-1470 |
| Works | 23 |

## Researcher papers

- [Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update](https://scholariq.org/papers/pulmonary-arterial-hypertension-a-pharmacotherapeutic-update/)
- [The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding](https://scholariq.org/papers/the-real-world-use-of-combined-p-glycoprotein-and-moderate-cyp3a4-inhibitors/)
- [Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis](https://scholariq.org/papers/biomarker-trends-incidence-and-outcomes-of-immune-checkpoint-inhibitor-induced/)
- [The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/the-role-of-sgc-stimulators-and-activators-in-heart-failure-with-reduced/)
- [An Update on the Management of Pulmonary Arterial Hypertension and the Pharmacist’s Role](https://scholariq.org/papers/an-update-on-the-management-of-pulmonary-arterial-hypertension-and-the/)
- [Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes](https://scholariq.org/papers/pharmacotherapy-considerations-with-finerenone-in-the-treatment-of-chronic/)
- [Tacrolimus time in therapeutic range and long‐term outcomes in heart transplant recipients](https://scholariq.org/papers/tacrolimus-time-in-therapeutic-range-and-long-term-outcomes-in-heart-transplant/)
- [Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl)](https://scholariq.org/papers/effects-of-total-dose-infusion-of-iron-intravenously-in-patients-with-acute/)
- [Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension](https://scholariq.org/papers/overview-of-riociguat-and-its-role-in-the-treatment-of-pulmonary-hypertension/)
- [Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method](https://scholariq.org/papers/development-of-best-practice-recommendations-for-the-safe-use-of-pulmonary/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

## Researcher university

- [University School](https://scholariq.org/institutions/university-school/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.